Background and Purpose: The literature is still controversial in relation to therapeutic differences between innovative, generic, and similar anti-seizures medications (ASM). Topiramate (TPM) is an ASM used in the treatment of various seizure types and in different epileptic syn...
Background and Purpose: Perampanel is approved for the adjunctive treatment of focal-onset seizures (FOS) with or without secondary generalized seizures. The FAME (Fycompa® as first Add-on to Monotherapy in patients with Epilepsy; NCT02726074) study evaluated the effi...
Background and Purpose: FAME (Fycompa® as first Add-on to Monotherapy in patients with Epilepsy; NCT02726074), a previously reported single-arm, phase IV study, showed that perampanel improved seizure control as first add-on to failed anti-seizure medication (ASM) mon...
If anyone registers his/her email address, he or she will receive the email of notification when new paper is published in the web site of JER.
Please Sign up.
To submit a manuscript, please visit the J Epilepsy Res e-submission management system at http://submit.j-epilepsy.org, read the Instructions for Authors, and log into the J Epilepsy Res e-submission system. For assistance with manuscript submission, please contact: 40403@snuh.org.
Free archive
Anyone may access any past or current articles without logging in.
Manuscript Submission